IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 176 filers reported holding IVERIC BIO INC in Q4 2021. The put-call ratio across all filers is 0.12 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $24,114,437 | +61.7% | 612,975 | 0.0% | 6.59% | +47.5% |
| Q1 2023 | $14,913,682 | +15.0% | 612,975 | +1.2% | 4.47% | +22.4% |
| Q4 2022 | $12,973,925 | +80.1% | 605,975 | +50.9% | 3.65% | +88.6% |
| Q3 2022 | $7,202,000 | +86.0% | 401,476 | -0.2% | 1.94% | +83.6% |
| Q2 2022 | $3,872,000 | -22.9% | 402,476 | +34.8% | 1.06% | -19.4% |
| Q1 2022 | $5,023,000 | +8.9% | 298,476 | +8.2% | 1.31% | +12.8% |
| Q4 2021 | $4,614,000 | +31.3% | 275,976 | +27.6% | 1.16% | +24.5% |
| Q3 2021 | $3,514,000 | +209.6% | 216,351 | +20.2% | 0.93% | +293.2% |
| Q2 2021 | $1,135,000 | +104.1% | 179,951 | +100.1% | 0.24% | +79.5% |
| Q1 2021 | $556,000 | +16.8% | 89,951 | +30.5% | 0.13% | -7.0% |
| Q4 2020 | $476,000 | -73.8% | 68,951 | -78.6% | 0.14% | -76.0% |
| Q3 2020 | $1,819,000 | -0.2% | 322,500 | -9.8% | 0.59% | +12.4% |
| Q2 2020 | $1,823,000 | – | 357,500 | – | 0.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
| Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
| Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
| MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
| Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
| ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
| Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
| Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
| Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
| Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |